Remedy Plan Therapeutics
Tom is the President of Tempest Therapeutics. Previously he served as the CSO at Aduro, Immune Design, and Anza.
This person is not in the org chart
This person is not in any offices
Remedy Plan Therapeutics
Remedy Plan is a biotechnology company developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.